Leerink Partners analyst Puneet Souda maintained a Hold rating on 908 Devices on July 8. The company’s shares closed yesterday at $7.22.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Souda covers the Healthcare sector, focusing on stocks such as Quanterix, Exact Sciences, and 908 Devices. According to TipRanks, Souda has an average return of -9.6% and a 33.60% success rate on recommended stocks.
Currently, the analyst consensus on 908 Devices is a Moderate Buy with an average price target of $7.00.
MASS market cap is currently $253.5M and has a P/E ratio of -3.37.
Based on the recent corporate insider activity of 21 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of MASS in relation to earlier this year. Most recently, in May 2025, Kevin J. Knopp, the President & CEO of MASS bought 15,000.00 shares for a total of $66,450.00.
Read More on MASS:
- 908 Devices Appoints Dr. Brown to Board
- 908 Devices Holds Annual Meeting, Elects Directors
- Positive Buy Rating for 908 Devices Following Strong Q1 Performance and Revised EBITDA Outlook
- 908 Devices Inc. Earnings Call: Growth Amid Challenges
- Hold Rating on 908 Devices Amidst Uncertainties and Strategic Shifts